Vivendy makes management and board changes
This article was originally published in Scrip
Executive Summary
Vivendy Therapeutics(Switzerland) has announced that its chief executive officer, Dr Roland Toder, is stepping down on September 30th. Vivendy has nominated Dr Gosse Bruinsma to its board, and anticipates that this nomination will be ratified at the company's next shareholder meeting. Dr Bruinsma, who most recently served as executive chairman at Curidium Medica, will also assume an executive function, which will encompass the activities of the CEO.
You may also be interested in...
Fujifilm Demonstrates Health Specialism With European HealthTech Spinout
From X-ray film in 1936 to the world’s first digital X-ray system in 1983, Fujifilm has a long heritage in medical diagnostics.
Financing Quarterly Statistics, Q1 2024
During Q1, biopharmas brought in an aggregate $30.1bn in financing and device company fundraising totaled $2.8bn; while in vitro diagnostic firms and research tools players raised $724m.
Helping Organizations Deliver On KPIs And Giving Staff A Voice
ImproveWell has won awards for its software technology that allows health care staff at the sharp end of patient care to report on problems as they happen. The outcome is a real-time learning process that contributes to improved operational efficiencies for health systems, says In Vivo Rising Leader Lara Mott.